Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Wenwen Chen, Lin He, Lian Zhong, Jiayi Sun, Lilin Zhang, Daneng Wei & Chunjie Wu. (2021) Identification of Active Compounds and Mechanism of Huangtu Decoction for the Treatment of Ulcerative Colitis by Network Pharmacology Combined with Experimental Verification. Drug Design, Development and Therapy 15, pages 4125-4140.
Read now
Read now
Articles from other publishers (16)
Lifei-Luo, Jingze Zhang, Xinyu Li, Yanru Zhu, Yansheng Wang & Dailin Liu. (2023) Sericic Acid Ameliorates DSS-induced Ulcerative Colitis in Mice by Modulating
the NF-κB and Nrf2 Pathways. Current Molecular Pharmacology 16:7.
Crossref
Crossref
Rui-Bin Zhang, Long-Cong Dong, Qin Huang, Yuan Shen, Hong-Ying Li, Shu-Guang Yu & Qiao-Feng Wu. (2023) Matrix metalloproteinases are key targets of acupuncture in the treatment of ulcerative colitis. Experimental Biology and Medicine.
Crossref
Crossref
Habiba Khdair Abdalsada, Hadi Hassan Hadi, Abbas F. Almulla, Asawer Hassan Najm, Ameer Al-Isa & Hussein Kadhem Al-Hakeim. (2023) Correlation of Stromelysin-1 and Tissue Inhibitor of Metalloproteinase-1 with Lipid Profile and Atherogenic Indices in End-Stage Renal Disease Patients: A Neural Network Study. Pertanika Journal of Science and Technology 31:4.
Crossref
Crossref
Andrey V. Markov, Innokenty A. Savin, Marina A. Zenkova & Aleksandra V. Sen’kova. (2023) Identification of Novel Core Genes Involved in Malignant Transformation of Inflamed Colon Tissue Using a Computational Biology Approach and Verification in Murine Models. International Journal of Molecular Sciences 24:5, pages 4311.
Crossref
Crossref
Kun Mei, Zilu Chen, Qin Wang, Yi Luo, Yan Huang, Bin Wang & Renjun Gu. (2023) The role of intestinal immune cells and matrix metalloproteinases in inflammatory bowel disease. Frontiers in Immunology 13.
Crossref
Crossref
Eric J. Lebish, Natalie J. Morgan, John F. Valentine & Ellen J. Beswick. (2022) MK2 Inhibitors as a Potential Crohn’s Disease Treatment Approach for Regulating MMP Expression, Cleavage of Checkpoint Molecules and T Cell Activity. Pharmaceuticals 15:12, pages 1508.
Crossref
Crossref
Ying Li, Mengyao Tang, Feng Jun Zhang, Yihan Huang, Jing Zhang, Junqi Li, Yunpeng Wang, Jinguang Yang & Shu Zhu. (2022) Screening of ulcerative colitis biomarkers and potential pathways based on weighted gene co-expression network, machine learning and ceRNA hypothesis. Hereditas 159:1.
Crossref
Crossref
Jiang Deng, Ning Zhao, Li-ping Lv, Ping Ma, Yang-yang Zhang, Jin-bo Xu, Xi-peng Zhou, Zi-an Chen & Yan-yu Zhang. (2022) Integrated analysis of multiple microarray studies to establish differential diagnostic models of Crohn’s disease and ulcerative colitis based on a metalloproteinase-associated module. Frontiers in Immunology 13.
Crossref
Crossref
Ying Xiao, Haifeng Lian, Xiaoying S. Zhong, Srikruthi S. Krishnachaitanya, Yingzi Cong, Roderick H. Dashwood, Tor C. Savidge, Don W. Powell, Xiaowei Liu & Qingjie Li. (2022) Matrix metalloproteinase 7 contributes to intestinal barrier dysfunction by degrading tight junction protein Claudin-7. Frontiers in Immunology 13.
Crossref
Crossref
Anna Hrabia, Katarzyna B. Miska, Lori L. Schreier & Monika Proszkowiec-Weglarz. (2022) Altered gene expression of selected matrix metalloproteinase system proteins in the broiler chicken gastrointestinal tract during post-hatch development and coccidia infection. Poultry Science 101:8, pages 101915.
Crossref
Crossref
Marta S. Alexdottir, Arno R. Bourgonje, Morten A. Karsdal, Martin Pehrsson, Roberta Loveikyte, Hendrik M. van Dullemen, Marijn C. Visschedijk, Eleonora A. M. Festen, Rinse K. Weersma, Klaas Nico Faber, Gerard Dijkstra & Joachim H. Mortensen. (2022) Serological Biomarkers of Extracellular Matrix Turnover and Neutrophil Activity Are Associated with Long-Term Use of Vedolizumab in Patients with Crohn’s Disease. International Journal of Molecular Sciences 23:15, pages 8137.
Crossref
Crossref
Aleksandra Czajkowska, Katarzyna Guzinska-Ustymowicz, Anna Pryczynicz, Dariusz Lebensztejn & Urszula Daniluk. (2022) Are Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 Useful as Markers in Diagnostic Management of Children with Newly Diagnosed Ulcerative Colitis?. Journal of Clinical Medicine 11:9, pages 2655.
Crossref
Crossref
Zili Lei, Wanwan Liu, Ya Nie, Yanhong Yang, Guibin Chen, Li Huang, Huijuan Wu, Yuting Lei, Lei Chen, Qing Hu, Hedong Rong, Siping Yu, Qi Song, Fengxue Tong & Jiao Guo. (2022) EpCAM Is Essential to Maintaining the Immune Homeostasis of Intestines via Keeping the Expression of pIgR in the Intestinal Epithelium of Mice. Frontiers in Immunology 13.
Crossref
Crossref
Dongjuan Song, Lijie Lai, Juntao Lu, Jinlu Tong & Zhihua Ran. (2022) Interleukin-26 Expression in Inflammatory Bowel Disease and Its Immunoregulatory Effects on Macrophages. Frontiers in Medicine 9.
Crossref
Crossref
Luis G. Guijarro, David Cano-Martínez, M.Val Toledo-Lobo, Patricia Sanmartín Salinas, María Chaparro, Ana M. Gómez-Lahoz, Sofía Zoullas, Rosa Rodríguez-Torres, Irene D. Román, Laura Sebastián Monasor, Lidia Ruiz-Llorente, María del Carmen Boyano-Adánez, Iván Guerra, Marisa Iborra, José Luis Cabriada, Luis Bujanda, Carlos Taxonera, Valle García-Sánchez, Ignacio Marín-Jiménez, Manuel Barreiro-de Acosta, Isabel Vera, María Dolores Martín-Arranz, Francisco Mesonero, Laura Sempere, Fernando Gomollón, Joaquín Hinojosa, Melchor Alvarez-Mon, Javier P. Gisbert, Miguel A. Ortega, Borja Hernández-Breijo & on behalf of the PREDICROHN study group from GETECCU. (2021) Relationship between IGF-1 and body weight in inflammatory bowel diseases: Cellular and molecular mechanisms involved. Biomedicine & Pharmacotherapy 144, pages 112239.
Crossref
Crossref
Kevin J. Roberts, Marion F. Cubitt, Timothy M. Carlton, Lurdes Rodrigues-Duarte, Luana Maggiore, Ray Chai, Simon Clare, Katherine Harcourt, Thomas T. MacDonald, Keith P. Ray, Anna Vossenkämper, Michael R. West & J. Scott Crowe. (2021) Preclinical development of a bispecific TNFα/IL-23 neutralising domain antibody as a novel oral treatment for inflammatory bowel disease. Scientific Reports 11:1.
Crossref
Crossref